GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lidds AB (OSTO:LIDDS) » Definitions » Float Percentage Of Total Shares Outstanding

Lidds AB (OSTO:LIDDS) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Lidds AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lidds AB's float shares is 0.00 Mil. Lidds AB's total shares outstanding is 136.46 Mil. Lidds AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lidds AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lidds AB's Institutional Ownership is 0.00%.


Lidds AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Lidds AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/136.46
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lidds AB (OSTO:LIDDS) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lidds AB (OSTO:LIDDS) » Definitions » Float Percentage Of Total Shares Outstanding
Traded in Other Exchanges
N/A
Address
Kullagatan 8, Helsingborg, SWE, 25220
Lidds AB is a Swedish pharmaceutical company developing pharmaceutical products based on medical needs and its proprietary drug delivery technology.

Lidds AB (OSTO:LIDDS) Headlines

No Headlines